- Report
- January 2024
- 150 Pages
Global
From €4596EUR$4,850USD£3,879GBP
- Report
- April 2021
China
From €2464EUR$2,600USD£2,079GBP
- Report
- January 2021
- 120 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- April 2022
- 233 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- March 2021
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- November 2023
- 182 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- April 2023
- 112 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- March 2023
- 113 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- February 2024
- 110 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Drug Pipelines
- February 2024
- 60 Pages
Global
From €1421EUR$1,500USD£1,200GBP
- Clinical Trials
- January 2024
- 120 Pages
Global
From €2843EUR$3,000USD£2,399GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €2843EUR$3,000USD£2,399GBP
- Report
- June 2023
- 241 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- April 2023
- 350 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- April 2023
- 500 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- April 2023
- 180 Pages
Global
From €2843EUR$3,000USD£2,399GBP
- Report
- October 2022
- 300 Pages
Global
From €3743EUR$3,950USD£3,159GBP
- Report
- October 2022
- 100 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- September 2022
- 239 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- August 2022
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis.
Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life.
The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more